
Shionogi, established in 1878, is dedicated to developing innovative treatments for global health challenges such as antimicrobial resistance and COVID-19. With a history of introducing novel antibiotics and advanced medications for HIV and influenza, the company continues to advance clinical programs in areas like Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. Driven by a commitment to patient impact, Shionogi fosters strategic partnerships with industry leaders to accelerate scientific advancements and deliver first-in-class therapies worldwide.
The Key Account Manager (KAM) position is responsible for establishing access and demand for a novel hospital antibiotic product to hospitals and hospital systems within an assigned territory. The KAM will educate formulary decision makers, key stakeholders, and clinicians on the clinical benefits of the product and establish formulary adoption within the institutional IV antibiotic space.
Shionogi, established in 1878, is dedicated to developing innovative treatments for global health challenges such as antimicrobial resistance and COVID-19. With a history of introducing novel antibiotics and advanced medications for HIV and influenza, the company continues to advance clinical programs in areas like Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. Driven by a commitment to patient impact, Shionogi fosters strategic partnerships with industry leaders to accelerate scientific advancements and deliver first-in-class therapies worldwide.